Pharma's Global Economic Outlook: Balancing Regional Challenges With International Opportunities

Presenting a partnership between Ensera Design & AstraZeneca to design and develop a combination drug delivery packaging ecosystem at pace and without compromise. Lucy Baldwin will take you through how Inclusive Design methodologies and Finite Element Analysis were used in combination to maximise user value and minimise risk to take AstraZeneca from contextual research discovery to design freeze in 8 months.

The Pharma industry is being hit simultaneously by multiple, highly complex, rapidly changing issues - ranging from next-generation innovation powered by AI through to unstable tariff regimes, pricing negotiations, regional manufacturing risks and supply chain issues, regulatory harmonisation and so on. Yet at the same time we are seeing huge opportunities created by blockbuster therapies for conditions such as obesity. How do we navigate these complexities, to accelerate drug discovery, development, and approval, while managing costs and risks? Key to this will be winning the public debate about the importance of a well-funded, vibrant, Pharma industry, on which the future health of humanity will depend.